| |
|
|
| Name: |
Cutter Capital Management LP |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10019 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
23 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
AMGN |
Amgen Inc |
1 |
- |
$273.94 |
$16,527,000 |
57,381 |
7.9% |
0 |
0 |
0.01 |
Biotechnology |
|
|
MRK |
Merck & Co Inc |
2 |
- |
$131.20 |
$14,837,000 |
136,098 |
7.09% |
0 |
0 |
0.005 |
Drug Manufacturers - ... |
|
|
FOLD |
Amicus Therapeutics Inc |
3 |
- |
$10.61 |
$13,444,000 |
947,418 |
6.43% |
0 |
0 |
0.279 |
Biotechnology |
|
|
INSM |
Insmed Inc |
4 |
- |
$24.72 |
$12,814,000 |
413,499 |
6.13% |
0 |
0 |
0.273 |
Biotechnology |
|
|
BMRN |
Biomarin Pharmaceutical Inc |
5 |
- |
$88.63 |
$12,526,000 |
129,906 |
5.99% |
0 |
0 |
0.069 |
Drug Manufacturers - ... |
|
|
ROIV |
Roivant Sciences Ltd. |
6 |
- |
$10.90 |
$11,230,000 |
1,000,000 |
5.37% |
0 |
0 |
0.145 |
N/A |
|
|
EXEL |
Exelixis Inc |
7 |
- |
$23.46 |
$11,091,000 |
462,305 |
5.3% |
0 |
0 |
0.149 |
Research Services |
|
|
TEVA |
Teva Pharmaceutical Industr... |
8 |
- |
$14.05 |
$11,084,000 |
1,061,668 |
5.3% |
0 |
0 |
0.097 |
Drug Manufacturers - ... |
|
|
RPRX |
Royalty Pharma Plc |
9 |
- |
$27.70 |
$10,393,000 |
370,000 |
4.97% |
0 |
0 |
0.101 |
N/A |
|
|
ACAD |
Acadia Pharmaceuticals Inc |
10 |
- |
$16.71 |
$10,363,000 |
330,973 |
4.95% |
0 |
0 |
0.206 |
Biotechnology |
|
|
BCRX |
Biocryst Pharmaceuticals Inc |
11 |
- |
$4.13 |
$9,116,000 |
1,521,812 |
4.36% |
0 |
0 |
0.862 |
Biotechnology |
|
|
HALO |
Halozyme Therapeutics Inc |
12 |
- |
$38.10 |
$8,887,000 |
240,448 |
4.25% |
0 |
0 |
0.175 |
Biotechnology |
|
|
PRGO |
Perrigo Co |
13 |
- |
$32.66 |
$8,367,000 |
260,000 |
4% |
0 |
0 |
0.191 |
Drug Related Products |
|
|
PFE |
Pfizer Inc |
14 |
- |
$25.62 |
$7,629,000 |
265,000 |
3.65% |
0 |
0 |
0.005 |
Drug Manufacturers - ... |
|
|
BMY |
Bristol-Myers Squibb Co |
15 |
- |
$43.94 |
$7,183,000 |
140,000 |
3.43% |
0 |
0 |
0.006 |
Drug Manufacturers - ... |
|
|
CRSP |
Crispr Therapeutics Ag |
16 |
- |
$52.99 |
$6,730,000 |
107,500 |
3.22% |
0 |
0 |
0.152 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
17 |
- |
$13.26 |
$6,702,000 |
307,721 |
3.2% |
0 |
0 |
0.679 |
N/A |
|
|
APLS |
Apellis Pharmaceuticals Inc |
18 |
- |
$44.19 |
$6,465,000 |
108,000 |
3.09% |
0 |
0 |
0.094 |
N/A |
|
|
IOVA |
Iovance Biotherapeutics Inc |
19 |
- |
$11.78 |
$5,507,000 |
677,350 |
2.63% |
0 |
0 |
0.317 |
N/A |
|
|
CABA |
Cabaletta Bio, Inc. |
20 |
- |
$0.00 |
$5,221,000 |
230,000 |
2.5% |
0 |
0 |
0.889 |
N/A |
|
|
PBH |
Prestige Brands Holdings Inc |
21 |
- |
$71.76 |
$5,204,000 |
85,000 |
2.49% |
0 |
0 |
0.166 |
Diagnostic Substances |
|
|
BBIO |
Bridgebio Pharma, Inc. |
22 |
- |
$25.62 |
$4,171,000 |
103,324 |
1.99% |
0 |
0 |
0.065 |
N/A |
|
|
RCUS |
Arcus Biosciences Inc |
23 |
- |
$15.23 |
$3,680,000 |
192,667 |
1.76% |
0 |
0 |
0.297 |
N/A |
|
